Gut Matters: Revealing the Connection between the Gut and Cardiometabolic Health

When the gut microbiome is out of balance or inflamed, the impact is felt throughout the body, including the cardiometabolic system. If the gut is healthy and functioning properly, microbial metabolites, such as lipopolysaccharide (LPS) and other antigens, are appropriately contained within the gut lumen. However, a dysfunctional, permeable intestinal barrier allows microbial antigens and metabolites to be translocated from the gut into the bloodstream. Once intestinal permeability allows LPS and other microbial antigens to escape into circulation, they can trigger immune responses, contributing to metabolic and cardiovascular health issues.

In this incisive new presentation, Dr. Robert Silverman leads you through the intricate interplay between gut microbiota composition, gut permeability, immune-inflammatory responses, metabolic pathways, and their collective influence on cardiometabolic well-being. You’ll come away with a thorough understanding of new functional medicine strategies to improve GI function and reduce cardiometabolic risk, leading to optimal health.

This presentation will review clinical assessments used to evaluate intestinal barrier integrity and laboratory testing used in clinical practice to assess markers associated with microbial toxins and immune responses related to metabolic health. Dr. Silverman will also discuss clinical approaches and strategies aimed at supporting intestinal barrier function and addressing gut dysbiosis.

Learning Objectives:

1. Elucidate the effect of intestinal barrier dysfunction on the cardiometabolic system and its role in the processes of cardiometabolic function.

2. Apply advanced diagnostic laboratory testing and blood chemistry analysis to assess intestinal dysfunctions.

3. Discuss how spore-based probiotics, precision prebiotics, and serum-derived immunoglobulin support microbial diversity, intestinal barrier function, and immune modulation, which are key upstream factors associated with metabolic health.

4. Identify considerations for the clinical application of microbiome-support strategies to optimize metabolic health.